食管切除术治疗良性疾病比恶性疾病术后并发症发生率更高
基于美国胸外科医师学会数据库2010至2018年的回顾性研究,纳入16,392例食管切除术患者,其中恶性14,871例(91%)、良性1,521例(9%)。经1:1倾向性评分匹配后,良性病变患者术后主要并发症更多(P=.001),但术后死亡率相似(P=.62);结论认为良性病变食管切除术围手术期并发症更差。
要点
- 良性病变食管切除术患者术后主要并发症发生率高于恶性病变患者(P=.001)。
- 两组术后死亡率无显著差异(P=.62)。
- 良性病变患者术中及术后输血更多、插管时间更长。
核心结论
- 良性病变行食管切除术与恶性病变相比围手术期并发症更差。
研究设计与样本
- 回顾性研究,基于美国胸外科医师学会数据库,纳入2010至2018年所有食管切除术患者,排除急诊或姑息性食管切除术者。
主要发现
- 16,392例患者中,恶性14,871例(91%),良性1,521例(9%)。
- 恶性病变患者年龄更大(P < .001)、男性更多(83% vs 56%,P < .001)、合并症更多(P < .001)。
- 倾向性评分匹配后共1,362对;恶性病变更常采用微创入路(P < .001)。
- 良性病变术中输血更多(P < .001)、术后插管时间更长(P = .02)、术后输血更多(P = .001)。
- 良性病变主要并发症更多(P = .001),但术后死亡率相似(P = .62)。
临床怎么用
- 作者认为应就预期结果对患者进行咨询,并考虑将该变量纳入风险评估的综合评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Esophagectomy carries a high risk of morbidity and mortality. The most common indication for esophagectomy is esophageal cancer, with fewer than 5% of esophagectomies performed for benign disease. We hypothesized that esophagectomy for benign disease is associated with a higher risk of operative and postoperative complications. METHODS: A retrospective study of The Society of Thoracic Surgeons database was performed to identify all patients who had an esophagectomy from 2010 to 2018. Patients who had an emergent or palliative esophagectomy were excluded. Patients were compared based on the indication for operation, malignant vs benign disease. A 1:1 propensity score matching of The Society of Thoracic Surgeons risk factors was performed and outcomes compared between the matched cohorts. RESULTS: Of 16,392 patients, 14,871 (91%) had malignant disease and 1521 (9%) had benign disease that met inclusion criteria. Patients with malignant disease were older (P < .001), more likely to be male (83% vs 56%, P < .001), and had more comorbidities (P < .001). There were 1362 propensity-matched pairs. Malignant esophagectomies were more likely to be performed with a minimally invasive vs an open approach (P < .001). Benign operations had more intraoperative blood transfusions (P < .001). Patients undergoing esophagectomy for benign disease had more prolonged intubations (P = .02) and postoperative blood transfusions (P = .001). Benign disease had more major morbidities (P = .001) but similar postoperative mortality (P = .62). CONCLUSIONS: Esophagectomy for benign disease is associated with worse perioperative morbidity compared with esophagectomy for malignant disease. Given these findings patients should be counseled on expected outcomes, and this variable should be considered for inclusion in the composite score for risk assessment.
引用
- Worrell SG, Gupta S, Alvarado CE, et al. Morbidity After Esophagectomy Is Higher for Benign Than Malignant Disease. Ann Thorac Surg. 2022. PMID: 36126720. doi:10.1016/j.athoracsur.2022.08.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。